Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The ketogenic diet: 1997

T D Swink1, E P Vining, J M Freeman

  • 1Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Advances in Pediatrics
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rights, respect for dignity and end-of-life care: time for a change in the concept of informed consent.

Journal of medical ethics·2009
Same author

Ethical theory and medical ethics: a personal perspective.

Journal of medical ethics·2006
Same author

Practice parameter: evaluation of the child with global developmental delay.

Neurology·2003
Same author

Hemispherectomy for intractable unihemispheric epilepsy etiology vs outcome.

Neurology·2003
Same author

The postoperative course and management of 106 hemidecortications.

Pediatric neurosurgery·2002
Same author

Levetiracetam psychosis in children with epilepsy.

Epilepsia·2002
Same journal

Two Steps Forward-One Step Back: Keeping Pace with Advances.

Advances in pediatrics·2025
Same journal

Pediatric Lymphadenopathy.

Advances in pediatrics·2025
Same journal

Vascular and Gastrointestinal Access in Children.

Advances in pediatrics·2025
Same journal

The Ouchless Pediatric Emergency Department.

Advances in pediatrics·2025
Same journal

Seizures and Shaking in Newborns and Babies.

Advances in pediatrics·2025
Same journal

Procalcitonin in Pediatric Emergency Medicine.

Advances in pediatrics·2025
See all related articles

The ketogenic diet (KD) is an effective epilepsy treatment, offering a glucose-to-ketone metabolic shift. Understanding its anticonvulsant mechanism could lead to new epilepsy therapies.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Metabolism

Background:

  • Epilepsy is a neurological disorder often treated with medications.
  • The ketogenic diet (KD) has resurged as an effective treatment for difficult-to-control epilepsy, particularly in children.
  • KD offers advantages over medications, including higher success rates, fewer side effects, and lower cost.

Observation:

  • The KD's success rate in controlling seizures surpasses many available medications.
  • Reported side effects, including cognitive and allergic reactions, appear less frequent than with medications.
  • Despite its clinical efficacy, the precise biochemical mechanism underlying the KD's anticonvulsant effects remains largely unknown.

Findings:

  • The KD induces a fundamental shift in brain metabolism, utilizing ketone bodies instead of glucose as the primary energy substrate.

Related Experiment Videos

  • This metabolic alteration is critical for maintaining seizure threshold, though the exact process is unclear.
  • The brain's energy utilization for seizure control may differ from its energy use in normal function, suggesting distinct metabolic pathways.

    • Implications:

    • Investigating the metabolic differences between glucose and ketone utilization in the brain could reveal a specific biochemistry of epilepsy.
    • Understanding the KD's anticonvulsant mechanism may enable the development of targeted medications simulating its biochemical effects.
    • The KD provides a novel paradigm for epilepsy research, potentially stimulating new therapeutic strategies for this neurological condition.